Catalent Germany Schorndorf GmbH

The medicine is used to treat Meniere's disease (characterized by dizziness, nausea, vomiting, progressive hearing loss, and tinnitus) and for the symptomatic treatment of vestibular vertigo.

Dosage form: tablets

ATC: N07CA01

The medicine is used to treat Meniere's disease, which is characterized by dizziness (with nausea and/or vomiting), progressive hearing loss, and tinnitus. It also helps in the symptomatic treatment of vestibular vertigo.

Dosage form: tablets

ATC: N07CA01

The medicinal product is used in the treatment of Ménière's disease (characterized by dizziness with nausea and vomiting, progressive hearing loss, and tinnitus) and for the symptomatic treatment of vestibular vertigo.

Dosage form: tablets

ATC: N07CA01

The medicine is used in the treatment of Ménière's disease (manifesting as dizziness with nausea and vomiting, progressive hearing loss, and tinnitus) and for the symptomatic treatment of vestibular vertigo.

Dosage form: tablets

ATC: N07CA01

It is used in the treatment of Ménière's disease (manifesting as dizziness, nausea, vomiting, progressive hearing loss, and tinnitus) and for the symptomatic treatment of vestibular vertigo.

Dosage form: tablets

ATC: N07CA01

The medicine is used in adults to help them lose weight and maintain a low body weight. It is intended for people with obesity (BMI from 30 kg/m²) or people with overweight (BMI from 27 kg/m²) who have weight-related health problems, such as diabetes, high blood pressure, or abnormal blood lipid levels. It is used in conjunction with a low-calorie diet and physical activity.

Dosage form: capsules, hard modified release

ATC: A08AA51

The medicine is used in adults with obesity (BMI from 30 kg/m²) or overweight (BMI from 27 kg/m²) associated with health problems, such as diabetes or high blood pressure. It helps to reduce appetite and supports maintaining a low body weight in combination with diet and physical activity.

Dosage form: capsules, hard modified release

ATC: A08AA51

Qsiva is used in adults to help them lose weight and maintain a low body weight. It is intended for people with obesity (BMI from 30 kg/m²) or overweight (BMI from 27 kg/m²) who have weight-related health problems, such as diabetes, high blood pressure, or abnormal blood lipid levels. It is used in conjunction with a low-calorie diet and physical activity.

Dosage form: capsules, hard modified release

ATC: A08AA51

The medicine is used in adults to help with weight loss and maintaining a low body weight. It is intended for people with obesity (BMI from 30 kg/m²) or overweight (BMI from 27 kg/m²) who also have a weight-related health problem, such as high blood pressure, diabetes, or abnormal blood lipid levels. It is used in conjunction with a low-calorie diet and physical activity.

Dosage form: capsules, hard modified release

ATC: A08AA51

It is used in the treatment of Ménière's disease (manifesting as dizziness, nausea, vomiting, progressive hearing loss, and tinnitus) and in the symptomatic treatment of vestibular vertigo.

Dosage form: tablets

ATC: N07CA01

It is used to treat the symptoms of Ménière's disease, such as dizziness, nausea, vomiting, tinnitus, and hearing problems. It also helps with dizziness resulting from the abnormal functioning of the inner ear responsible for balance.

Dosage form: tablets

ATC: N07CA01